Sartorius Debuts the Intellicyt iQue3 at CYTO 2019
The latest solution offered in Sartorius’ cellular analysis portfolio is designed to fully automate processing and analysis for flow cytometry workflows
The latest solution offered in Sartorius’ cellular analysis portfolio is designed to fully automate processing and analysis for flow cytometry workflows
SelectScience attended this year’s AAI IMMUNOLOGY conference to bring you the latest news and technology in the field
Help us celebrate the best new clinical assays, kits, instruments and devices by casting your vote today
TTP enables development of MosaiQ™ diagnostic platform for transfusion typing and disease screening
Don’t miss April’s highlights thanks to our regular monthly round-up of all the most popular stories and resources in the clinical science community
Rapid, label-free imaging and volumetric analysis via HT-2 microscope studies the 4D interaction dynamics of T cells and their targets in the immunological synapse for the first time
New isotype-specific secondary antibodies promise improved signal detection and specificity in imaging
SelectScience reports on the top technologies launched at the American Association for Cancer Research (AACR) annual meeting, in Atlanta, USA
The tripartite mRNA technology has completed its phase 1b study for direct, intranodal injections in adjuvant melanoma patients
Learn how the latest next-generation automated assays are transforming our approach to drug discovery in the field of immuno-oncology
New research suggests that metal-based chemotherapies eliminate inhibitory components of the immune system
SelectScience is hosting two free CE-accredited events for healthcare professionals and laboratory scientists, but hurry - spots are filling up fast!
Multi-centre study published in New England Journal of Medicine suggests CAR-T therapy could improve outcome in B-cell lymphoma patients
From 3D tissue profiling to intelligent surgical tools, discover some of the latest innovations set to revolutionize diagnostics in cancer
Quantifying and targeting MDSCs, the ‘queen bee of the TME’, could overcome resistance to immunotherapy, Dr. R. J. Tesi tells SelectScience
Ready-to-use immunoassay kit designed to increase productivity